Innate Pharma to participate in upcoming investor conference

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that members of its senior management team are scheduled to participate in the following upcoming conference:  

  • H.C. Wainwright Immune Cell Engager Virtual Conference
  • Event Date: August 17 - virtual